

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 5.10797581 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.10797581 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.10797581 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.10797581 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.10797581 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.10797581 |
| 7 | response to muramyl dipeptide (GO:0032495) | 4.61832837 |
| 8 | regulation of vitamin metabolic process (GO:0030656) | 4.57509642 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.55848015 |
| 10 | response to peptidoglycan (GO:0032494) | 4.46035016 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 4.36248265 |
| 12 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.19768938 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.16749635 |
| 14 | positive regulation of heat generation (GO:0031652) | 4.01760560 |
| 15 | leukocyte aggregation (GO:0070486) | 3.98667182 |
| 16 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.97108166 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.83604878 |
| 18 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.80369992 |
| 19 | regulation of fever generation (GO:0031620) | 3.80345090 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.74869019 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.70800396 |
| 22 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.69620785 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.67796658 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.64227452 |
| 25 | T-helper 1 type immune response (GO:0042088) | 3.63012188 |
| 26 | granulocyte activation (GO:0036230) | 3.59470918 |
| 27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.59305051 |
| 28 | tolerance induction (GO:0002507) | 3.56333703 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.51459802 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51092754 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.48816724 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.48816724 |
| 33 | neutrophil activation (GO:0042119) | 3.48621463 |
| 34 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.48155665 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47436600 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.46625253 |
| 37 | positive regulation of type 2 immune response (GO:0002830) | 3.44515648 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 3.41869453 |
| 39 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.41561511 |
| 40 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.41551785 |
| 41 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.40706366 |
| 42 | response to host immune response (GO:0052572) | 3.39920574 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39920574 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.37854418 |
| 45 | regulation of chronic inflammatory response (GO:0002676) | 3.36087997 |
| 46 | positive regulation of antigen processing and presentation (GO:0002579) | 3.34054137 |
| 47 | myeloid dendritic cell differentiation (GO:0043011) | 3.31455181 |
| 48 | myeloid dendritic cell activation (GO:0001773) | 3.28250797 |
| 49 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27520412 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27082375 |
| 51 | respiratory burst (GO:0045730) | 3.24126820 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.22835708 |
| 53 | germinal center formation (GO:0002467) | 3.20474404 |
| 54 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.19914737 |
| 55 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.19396847 |
| 56 | activation of MAPKKK activity (GO:0000185) | 3.17683011 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15770754 |
| 58 | response to host (GO:0075136) | 3.15770754 |
| 59 | response to host defenses (GO:0052200) | 3.15770754 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15708827 |
| 61 | response to type I interferon (GO:0034340) | 3.14792322 |
| 62 | type I interferon signaling pathway (GO:0060337) | 3.13682544 |
| 63 | cellular response to type I interferon (GO:0071357) | 3.13682544 |
| 64 | interferon-gamma production (GO:0032609) | 3.12122747 |
| 65 | negative regulation of cell killing (GO:0031342) | 3.11559296 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11559296 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.06577293 |
| 68 | positive thymic T cell selection (GO:0045059) | 3.06493686 |
| 69 | regulation of chemokine biosynthetic process (GO:0045073) | 3.06082358 |
| 70 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.04959759 |
| 71 | detection of other organism (GO:0098543) | 3.03493668 |
| 72 | positive regulation of interleukin-12 production (GO:0032735) | 3.02622828 |
| 73 | regulation of antigen processing and presentation (GO:0002577) | 3.02297439 |
| 74 | leukocyte cell-cell adhesion (GO:0007159) | 3.02254022 |
| 75 | modulation by symbiont of host cellular process (GO:0044068) | 3.01307766 |
| 76 | positive regulation of humoral immune response (GO:0002922) | 3.00973012 |
| 77 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00392038 |
| 78 | T cell migration (GO:0072678) | 2.99708737 |
| 79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99288148 |
| 80 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.99045017 |
| 81 | regulation of mononuclear cell migration (GO:0071675) | 2.98444928 |
| 82 | defense response to protozoan (GO:0042832) | 2.93760553 |
| 83 | positive regulation of acute inflammatory response (GO:0002675) | 2.92645173 |
| 84 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92582295 |
| 85 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.92237575 |
| 86 | microglial cell activation (GO:0001774) | 2.92113652 |
| 87 | regulation of T-helper cell differentiation (GO:0045622) | 2.91722547 |
| 88 | regulation of interleukin-12 production (GO:0032655) | 2.90691336 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90269229 |
| 90 | positive regulation of interferon-beta production (GO:0032728) | 2.89626719 |
| 91 | regulation of heat generation (GO:0031650) | 2.89171053 |
| 92 | regulation of podosome assembly (GO:0071801) | 2.88856277 |
| 93 | regulation of immunoglobulin secretion (GO:0051023) | 2.88820060 |
| 94 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.88796206 |
| 95 | detection of bacterium (GO:0016045) | 2.88688230 |
| 96 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.87907737 |
| 97 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.87801560 |
| 98 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.85726904 |
| 99 | * cellular response to lipopolysaccharide (GO:0071222) | 2.85392891 |
| 100 | response to protozoan (GO:0001562) | 2.85312914 |
| 101 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.84843394 |
| 102 | positive regulation of interleukin-2 production (GO:0032743) | 2.84405414 |
| 103 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.83424687 |
| 104 | regulation of type 2 immune response (GO:0002828) | 2.83417692 |
| 105 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.82745905 |
| 106 | mature B cell differentiation (GO:0002335) | 2.81316146 |
| 107 | B cell mediated immunity (GO:0019724) | 2.78305325 |
| 108 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.78275892 |
| 109 | macrophage activation (GO:0042116) | 2.78174898 |
| 110 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.77972265 |
| 111 | cellular extravasation (GO:0045123) | 2.75358817 |
| 112 | negative regulation of lipid storage (GO:0010888) | 2.74400327 |
| 113 | cytokine secretion (GO:0050663) | 2.74051270 |
| 114 | positive regulation of B cell mediated immunity (GO:0002714) | 2.74024361 |
| 115 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.74024361 |
| 116 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.73912197 |
| 117 | positive regulation of interleukin-17 production (GO:0032740) | 2.73867651 |
| 118 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.73443485 |
| 119 | positive regulation of interleukin-6 production (GO:0032755) | 2.72657311 |
| 120 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.71326168 |
| 121 | monocyte chemotaxis (GO:0002548) | 2.71033702 |
| 122 | regulation of response to interferon-gamma (GO:0060330) | 2.70548029 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.70322819 |
| 124 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.70276015 |
| 125 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.70162403 |
| 126 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.69265287 |
| 127 | detection of molecule of bacterial origin (GO:0032490) | 2.68554427 |
| 128 | mature B cell differentiation involved in immune response (GO:0002313) | 2.68502561 |
| 129 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67598528 |
| 130 | myeloid leukocyte activation (GO:0002274) | 2.66705289 |
| 131 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.66522380 |
| 132 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.65964980 |
| 133 | cellular response to interferon-gamma (GO:0071346) | 2.65261170 |
| 134 | T-helper cell differentiation (GO:0042093) | 2.64791719 |
| 135 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.64791719 |
| 136 | positive regulation of B cell differentiation (GO:0045579) | 2.64227833 |
| 137 | superoxide anion generation (GO:0042554) | 2.64204701 |
| 138 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.64059434 |
| 139 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.63440232 |
| 140 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.63356066 |
| 141 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.63322637 |
| 142 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.61469394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.36591512 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.89666314 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.81839844 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.39602392 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.37538869 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.95512102 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71597262 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56041109 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.52103641 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45231214 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.44769522 |
| 12 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.24916252 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.24066414 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.10220941 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07508976 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.01613005 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.86334825 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70919356 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64603544 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64422907 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36614631 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28428127 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.23395032 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.12921964 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12019883 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.06516630 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01115252 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99496350 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96901243 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.96092172 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91614759 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.88566449 |
| 33 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.88129953 |
| 34 | * MYB_26560356_Chip-Seq_TH1_Human | 1.86421622 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81307718 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78737544 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75303022 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68253065 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64166122 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63186160 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.62949097 |
| 42 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62828182 |
| 43 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.60591978 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.58477419 |
| 45 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.58360815 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54358163 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.50705780 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50616595 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44486404 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43337308 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40767028 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39968978 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39793162 |
| 54 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.37684013 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35938921 |
| 56 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33312955 |
| 57 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30075430 |
| 58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28639202 |
| 59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26279535 |
| 60 | * MAF_26560356_Chip-Seq_TH2_Human | 1.26220049 |
| 61 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24518452 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24011314 |
| 63 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21967804 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18464487 |
| 65 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.18392615 |
| 66 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.18341006 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17848708 |
| 68 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17790046 |
| 69 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16426790 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15882652 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14052897 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12929375 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12882576 |
| 74 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10520533 |
| 75 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.08961931 |
| 76 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.08961931 |
| 77 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08701457 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08643226 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08217949 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05762763 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05080683 |
| 82 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04734227 |
| 83 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.03758159 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02710110 |
| 85 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.01860221 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.01152903 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00883917 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00618377 |
| 89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99291618 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98315759 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97594930 |
| 92 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96270897 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95605961 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95201458 |
| 95 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94712127 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94125287 |
| 97 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93925333 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.92888561 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91898922 |
| 100 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.91675517 |
| 101 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91150782 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91117594 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89111487 |
| 104 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87728064 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85996249 |
| 106 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85850738 |
| 107 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85723154 |
| 108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83733426 |
| 109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83340087 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82289856 |
| 111 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81001471 |
| 112 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77103644 |
| 113 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76737785 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76623599 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76024997 |
| 116 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75020745 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74657347 |
| 118 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.74074128 |
| 119 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73675975 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.72534395 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68936805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.79735915 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.67544580 |
| 3 | MP0003436_decreased_susceptibility_to | 3.56145108 |
| 4 | MP0009785_altered_susceptibility_to | 3.44664001 |
| 5 | MP0001790_abnormal_immune_system | 3.16303582 |
| 6 | MP0005387_immune_system_phenotype | 3.16303582 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.11362069 |
| 8 | MP0003724_increased_susceptibility_to | 3.06662484 |
| 9 | MP0000685_abnormal_immune_system | 3.01277422 |
| 10 | MP0004510_myositis | 2.90344153 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.88962952 |
| 12 | * MP0001800_abnormal_humoral_immune | 2.85372393 |
| 13 | MP0002419_abnormal_innate_immunity | 2.76983067 |
| 14 | MP0005671_abnormal_response_to | 2.72949054 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.71668488 |
| 16 | MP0005025_abnormal_response_to | 2.70714096 |
| 17 | * MP0002723_abnormal_immune_serum | 2.62387782 |
| 18 | MP0004947_skin_inflammation | 2.51717869 |
| 19 | MP0006082_CNS_inflammation | 2.47131632 |
| 20 | * MP0001819_abnormal_immune_cell | 2.35238260 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.34229377 |
| 22 | MP0002405_respiratory_system_inflammati | 2.23575688 |
| 23 | MP0009278_abnormal_bone_marrow | 2.18636972 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.10494598 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.08983635 |
| 26 | MP0005451_abnormal_body_composition | 2.03575315 |
| 27 | MP0008004_abnormal_stomach_pH | 2.00624757 |
| 28 | MP0001853_heart_inflammation | 2.00068103 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.94964479 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.86682495 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.85845958 |
| 32 | * MP0001845_abnormal_inflammatory_respons | 1.85002461 |
| 33 | * MP0002398_abnormal_bone_marrow | 1.82776907 |
| 34 | * MP0000716_abnormal_immune_system | 1.80109767 |
| 35 | MP0003448_altered_tumor_morphology | 1.78430947 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.77442866 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.74928531 |
| 38 | MP0002006_tumorigenesis | 1.72710524 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.54587831 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.54587831 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.53558803 |
| 42 | * MP0000689_abnormal_spleen_morphology | 1.52443708 |
| 43 | MP0009764_decreased_sensitivity_to | 1.52225286 |
| 44 | MP0003453_abnormal_keratinocyte_physiol | 1.50319925 |
| 45 | MP0002332_abnormal_exercise_endurance | 1.49260609 |
| 46 | MP0002933_joint_inflammation | 1.49100940 |
| 47 | MP0000858_altered_metastatic_potential | 1.47780566 |
| 48 | MP0001873_stomach_inflammation | 1.46954729 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.46419133 |
| 50 | * MP0002722_abnormal_immune_system | 1.45103887 |
| 51 | * MP0002429_abnormal_blood_cell | 1.44989092 |
| 52 | MP0008469_abnormal_protein_level | 1.41936521 |
| 53 | MP0000343_altered_response_to | 1.41598431 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.40719588 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.38701229 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.35817509 |
| 57 | MP0005310_abnormal_salivary_gland | 1.35618210 |
| 58 | MP0002254_reproductive_system_inflammat | 1.32466520 |
| 59 | MP0001851_eye_inflammation | 1.31878845 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.28998388 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.24584302 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.21896374 |
| 63 | MP0000604_amyloidosis | 1.21703160 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.17994864 |
| 65 | MP0003866_abnormal_defecation | 1.16168347 |
| 66 | MP0000490_abnormal_crypts_of | 1.14647018 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.13770678 |
| 68 | MP0005390_skeleton_phenotype | 1.09184293 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.05121547 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.04553962 |
| 71 | MP0003075_altered_response_to | 1.03862866 |
| 72 | MP0009840_abnormal_foam_cell | 1.00930518 |
| 73 | MP0003828_pulmonary_edema | 0.99412172 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.95885362 |
| 75 | MP0010307_abnormal_tumor_latency | 0.95770094 |
| 76 | MP0001216_abnormal_epidermal_layer | 0.93755588 |
| 77 | MP0005023_abnormal_wound_healing | 0.93692613 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.92267841 |
| 79 | MP0005166_decreased_susceptibility_to | 0.91321063 |
| 80 | MP0006054_spinal_hemorrhage | 0.90586304 |
| 81 | MP0008260_abnormal_autophagy | 0.90095824 |
| 82 | MP0003690_abnormal_glial_cell | 0.87490232 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.85895100 |
| 84 | MP0002396_abnormal_hematopoietic_system | 0.84725838 |
| 85 | MP0002796_impaired_skin_barrier | 0.83144701 |
| 86 | MP0003091_abnormal_cell_migration | 0.83074395 |
| 87 | MP0009763_increased_sensitivity_to | 0.80536674 |
| 88 | MP0001542_abnormal_bone_strength | 0.78391293 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.77713356 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 0.77629973 |
| 91 | MP0002060_abnormal_skin_morphology | 0.75253696 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 0.74467241 |
| 93 | MP0003195_calcinosis | 0.74287567 |
| 94 | MP0005165_increased_susceptibility_to | 0.73926375 |
| 95 | MP0001191_abnormal_skin_condition | 0.73354322 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.73242728 |
| 97 | MP0000249_abnormal_blood_vessel | 0.73226759 |
| 98 | MP0003795_abnormal_bone_structure | 0.72734166 |
| 99 | MP0001881_abnormal_mammary_gland | 0.71144187 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.70600792 |
| 101 | MP0005164_abnormal_response_to | 0.69903837 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.69402894 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.68537714 |
| 104 | MP0001501_abnormal_sleep_pattern | 0.68050126 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.67775908 |
| 106 | MP0004883_abnormal_blood_vessel | 0.67225769 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.67127340 |
| 108 | MP0001663_abnormal_digestive_system | 0.66235911 |
| 109 | MP0003045_fibrosis | 0.65943899 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.65907909 |
| 111 | MP0004381_abnormal_hair_follicle | 0.65309631 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.64198608 |
| 113 | MP0008874_decreased_physiological_sensi | 0.63575713 |
| 114 | MP0000627_abnormal_mammary_gland | 0.63286992 |
| 115 | MP0009931_abnormal_skin_appearance | 0.61945481 |
| 116 | MP0001243_abnormal_dermal_layer | 0.61595071 |
| 117 | MP0000609_abnormal_liver_physiology | 0.60730388 |
| 118 | MP0005257_abnormal_intraocular_pressure | 0.60243860 |
| 119 | MP0008057_abnormal_DNA_replication | 0.57310467 |
| 120 | MP0003705_abnormal_hypodermis_morpholog | 0.57133776 |
| 121 | MP0008007_abnormal_cellular_replicative | 0.55629417 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.54059681 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.01334100 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.75670661 |
| 3 | Stomatitis (HP:0010280) | 5.52936132 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 5.28653566 |
| 5 | Optic neuritis (HP:0100653) | 5.28653566 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 5.22516415 |
| 7 | Myositis (HP:0100614) | 5.16812840 |
| 8 | Orchitis (HP:0100796) | 5.15131945 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.05073682 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.50786073 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.04905416 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.04854102 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99227864 |
| 14 | Vasculitis (HP:0002633) | 3.93135106 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.65315374 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.63853852 |
| 17 | Loss of speech (HP:0002371) | 3.60130137 |
| 18 | Obstructive lung disease (HP:0006536) | 3.52101898 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.52101898 |
| 20 | Pulmonary infiltrates (HP:0002113) | 3.51571217 |
| 21 | Pustule (HP:0200039) | 3.47921246 |
| 22 | Recurrent skin infections (HP:0001581) | 3.46269260 |
| 23 | Gingivitis (HP:0000230) | 3.45125792 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.40247228 |
| 25 | Recurrent viral infections (HP:0004429) | 3.35415038 |
| 26 | Keratoconjunctivitis (HP:0001096) | 3.16503364 |
| 27 | Increased IgE level (HP:0003212) | 3.14413523 |
| 28 | Arterial thrombosis (HP:0004420) | 3.09514120 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 3.05963152 |
| 30 | Meningitis (HP:0001287) | 3.05568153 |
| 31 | Cellulitis (HP:0100658) | 3.01679029 |
| 32 | IgM deficiency (HP:0002850) | 2.98555603 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98067999 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98067999 |
| 35 | Leukocytosis (HP:0001974) | 2.97840109 |
| 36 | Thick nail (HP:0001805) | 2.97479096 |
| 37 | Increased IgM level (HP:0003496) | 2.85183506 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 2.80117368 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77444952 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77444952 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77444952 |
| 42 | Chronic otitis media (HP:0000389) | 2.76029374 |
| 43 | Hemoptysis (HP:0002105) | 2.75584927 |
| 44 | Malnutrition (HP:0004395) | 2.72154964 |
| 45 | Disinhibition (HP:0000734) | 2.71474727 |
| 46 | Increased serum ferritin (HP:0003281) | 2.66140567 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64376765 |
| 48 | Mucopolysacchariduria (HP:0008155) | 2.64376765 |
| 49 | Eosinophilia (HP:0001880) | 2.62467783 |
| 50 | Nuclear cataract (HP:0100018) | 2.60445046 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.58951085 |
| 52 | Urticaria (HP:0001025) | 2.58017359 |
| 53 | Myocardial infarction (HP:0001658) | 2.57456325 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.56675684 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.56622795 |
| 56 | Gastrointestinal stroma tumor (HP:0100723) | 2.54819087 |
| 57 | Amyloidosis (HP:0011034) | 2.53016050 |
| 58 | Parakeratosis (HP:0001036) | 2.52020854 |
| 59 | Periodontitis (HP:0000704) | 2.50013065 |
| 60 | Osteomyelitis (HP:0002754) | 2.49801835 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.48834465 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.48301336 |
| 63 | Prostate neoplasm (HP:0100787) | 2.46418446 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.44723244 |
| 65 | T lymphocytopenia (HP:0005403) | 2.43747292 |
| 66 | Premature loss of primary teeth (HP:0006323) | 2.42759137 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.42142985 |
| 68 | Colitis (HP:0002583) | 2.39659806 |
| 69 | Emphysema (HP:0002097) | 2.38996047 |
| 70 | Abnormality of eosinophils (HP:0001879) | 2.38994099 |
| 71 | Anorexia (HP:0002039) | 2.38807357 |
| 72 | Nasal polyposis (HP:0100582) | 2.36399211 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.36369837 |
| 74 | Vacuolated lymphocytes (HP:0001922) | 2.36229970 |
| 75 | Glomerulonephritis (HP:0000099) | 2.35647484 |
| 76 | Increased density of long bones (HP:0006392) | 2.33857024 |
| 77 | Abnormality of T cells (HP:0002843) | 2.33141653 |
| 78 | Encephalitis (HP:0002383) | 2.32214684 |
| 79 | Granulocytopenia (HP:0001913) | 2.30308759 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.29478663 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.28833571 |
| 82 | Persistence of primary teeth (HP:0006335) | 2.27149543 |
| 83 | Gastrointestinal inflammation (HP:0004386) | 2.25612352 |
| 84 | Cheilitis (HP:0100825) | 2.25253613 |
| 85 | Basal ganglia calcification (HP:0002135) | 2.24999996 |
| 86 | Gangrene (HP:0100758) | 2.24518985 |
| 87 | Recurrent pneumonia (HP:0006532) | 2.24027033 |
| 88 | Thin bony cortex (HP:0002753) | 2.22925697 |
| 89 | Hematochezia (HP:0002573) | 2.21934052 |
| 90 | Skin ulcer (HP:0200042) | 2.21172742 |
| 91 | Gingival bleeding (HP:0000225) | 2.20418625 |
| 92 | Lymphopenia (HP:0001888) | 2.19964696 |
| 93 | IgA deficiency (HP:0002720) | 2.19111293 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19033502 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.17088359 |
| 96 | Thyroiditis (HP:0100646) | 2.14908458 |
| 97 | Abnormality of the pleura (HP:0002103) | 2.14337002 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.13642004 |
| 99 | Polyneuropathy (HP:0001271) | 2.10887126 |
| 100 | Petechiae (HP:0000967) | 2.10879407 |
| 101 | Arthralgia (HP:0002829) | 2.09694978 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.09212925 |
| 103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.08804133 |
| 104 | Abnormality of the nasal mucosa (HP:0000433) | 2.06832466 |
| 105 | Recurrent lower respiratory tract infections (HP:0002783) | 2.06271732 |
| 106 | Severe combined immunodeficiency (HP:0004430) | 2.06158247 |
| 107 | Agammaglobulinemia (HP:0004432) | 2.06090121 |
| 108 | Restrictive lung disease (HP:0002091) | 2.04123126 |
| 109 | Combined immunodeficiency (HP:0005387) | 2.03733282 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.01951764 |
| 111 | Abnormality of the pericardium (HP:0001697) | 2.01315498 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 2.00141402 |
| 113 | IgG deficiency (HP:0004315) | 1.99724074 |
| 114 | Mutism (HP:0002300) | 1.99342132 |
| 115 | Purpura (HP:0000979) | 1.98898187 |
| 116 | Chronic diarrhea (HP:0002028) | 1.96580334 |
| 117 | Chest pain (HP:0100749) | 1.94925867 |
| 118 | Apathy (HP:0000741) | 1.93991364 |
| 119 | Axonal loss (HP:0003447) | 1.93915935 |
| 120 | Glomerulopathy (HP:0100820) | 1.93785201 |
| 121 | Thrombocytosis (HP:0001894) | 1.93550766 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.92160936 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.92160936 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.92160936 |
| 125 | Episodic fever (HP:0001954) | 1.91900910 |
| 126 | Peritonitis (HP:0002586) | 1.91832355 |
| 127 | Joint swelling (HP:0001386) | 1.90993454 |
| 128 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89959819 |
| 129 | Diminished motivation (HP:0000745) | 1.87893757 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.86774265 |
| 131 | Asymmetric septal hypertrophy (HP:0001670) | 1.86390704 |
| 132 | Progressive neurologic deterioration (HP:0002344) | 1.86252697 |
| 133 | Acne (HP:0001061) | 1.83684380 |
| 134 | Pulmonary embolism (HP:0002204) | 1.82889412 |
| 135 | Keratitis (HP:0000491) | 1.79005045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.73906705 |
| 2 | MAP3K14 | 4.70936291 |
| 3 | MAP4K1 | 3.86852755 |
| 4 | TXK | 3.53558737 |
| 5 | TBK1 | 3.18067781 |
| 6 | PRPF4B | 2.81259467 |
| 7 | TYK2 | 2.79508973 |
| 8 | IRAK4 | 2.65765245 |
| 9 | IKBKE | 2.62681238 |
| 10 | RIPK4 | 2.38945618 |
| 11 | * IKBKB | 2.36733513 |
| 12 | JAK3 | 2.35721286 |
| 13 | BLK | 2.17193686 |
| 14 | JAK1 | 2.06462791 |
| 15 | CHUK | 2.03078230 |
| 16 | GRK7 | 2.01596439 |
| 17 | DDR2 | 1.98761927 |
| 18 | EPHB1 | 1.87235565 |
| 19 | STK10 | 1.76881008 |
| 20 | ERN1 | 1.71985050 |
| 21 | MST4 | 1.71275098 |
| 22 | ZAP70 | 1.70324900 |
| 23 | PIM2 | 1.64842791 |
| 24 | MAP3K10 | 1.57962825 |
| 25 | CSK | 1.57825201 |
| 26 | PIM1 | 1.49435448 |
| 27 | TAOK3 | 1.48541110 |
| 28 | RPS6KA4 | 1.45066233 |
| 29 | HCK | 1.43259155 |
| 30 | KIT | 1.42165454 |
| 31 | CDC42BPA | 1.40176615 |
| 32 | BTK | 1.39570247 |
| 33 | IRAK2 | 1.37312124 |
| 34 | SIK1 | 1.33162820 |
| 35 | MOS | 1.31227991 |
| 36 | TEC | 1.29559148 |
| 37 | EPHA3 | 1.28473982 |
| 38 | TRIB3 | 1.27136367 |
| 39 | SYK | 1.22018065 |
| 40 | FGFR4 | 1.16988653 |
| 41 | ITK | 1.16492153 |
| 42 | MAP3K13 | 1.16079560 |
| 43 | LCK | 1.15768821 |
| 44 | CLK1 | 1.10556600 |
| 45 | TGFBR2 | 1.09677371 |
| 46 | PBK | 1.09081613 |
| 47 | CDK12 | 1.08778426 |
| 48 | BMX | 1.07509453 |
| 49 | GRK6 | 1.06267216 |
| 50 | MARK3 | 1.05896807 |
| 51 | NLK | 1.01180724 |
| 52 | FGFR3 | 0.98520399 |
| 53 | SIK3 | 0.94964955 |
| 54 | LYN | 0.94244302 |
| 55 | NME2 | 0.93627759 |
| 56 | CSF1R | 0.93171356 |
| 57 | JAK2 | 0.90420391 |
| 58 | MAP3K3 | 0.81616452 |
| 59 | IRAK1 | 0.80276834 |
| 60 | EPHA2 | 0.79884962 |
| 61 | MAP2K3 | 0.79805517 |
| 62 | EIF2AK2 | 0.77451990 |
| 63 | ICK | 0.76416381 |
| 64 | FES | 0.75756434 |
| 65 | BMPR2 | 0.74075558 |
| 66 | MAP3K11 | 0.73694748 |
| 67 | TESK2 | 0.72567812 |
| 68 | LRRK2 | 0.72099688 |
| 69 | SIK2 | 0.70784079 |
| 70 | LATS2 | 0.70052605 |
| 71 | TRPM7 | 0.67831523 |
| 72 | FGR | 0.66199575 |
| 73 | STK4 | 0.64511738 |
| 74 | ABL1 | 0.64264175 |
| 75 | SMG1 | 0.63562598 |
| 76 | STK24 | 0.61241776 |
| 77 | MAPK7 | 0.60563260 |
| 78 | RPS6KA5 | 0.59328210 |
| 79 | ABL2 | 0.55885138 |
| 80 | PTK6 | 0.55690483 |
| 81 | MATK | 0.54991777 |
| 82 | TAOK2 | 0.54799241 |
| 83 | PDGFRA | 0.54619704 |
| 84 | STK3 | 0.54575045 |
| 85 | TYRO3 | 0.53377675 |
| 86 | MAPKAPK2 | 0.53230470 |
| 87 | ALK | 0.52863094 |
| 88 | ARAF | 0.52369425 |
| 89 | NEK9 | 0.52250531 |
| 90 | MST1R | 0.51134203 |
| 91 | MARK2 | 0.49309046 |
| 92 | RIPK1 | 0.48987935 |
| 93 | PDPK1 | 0.48386397 |
| 94 | PDK1 | 0.46951521 |
| 95 | TNK2 | 0.46144664 |
| 96 | RPS6KA1 | 0.44649629 |
| 97 | EGFR | 0.43940458 |
| 98 | RPS6KA6 | 0.42771971 |
| 99 | ADRBK2 | 0.41970312 |
| 100 | YES1 | 0.41664847 |
| 101 | MAP2K6 | 0.41329703 |
| 102 | CDK6 | 0.41163633 |
| 103 | MAP3K5 | 0.39955332 |
| 104 | PRKD2 | 0.39666984 |
| 105 | PRKCD | 0.37707686 |
| 106 | MAPK15 | 0.36444210 |
| 107 | GSK3A | 0.35789250 |
| 108 | KSR2 | 0.33828272 |
| 109 | CDK4 | 0.33287384 |
| 110 | MAPK11 | 0.32847030 |
| 111 | PRKG2 | 0.32700203 |
| 112 | PAK4 | 0.32169149 |
| 113 | PRKCQ | 0.31907654 |
| 114 | RPS6KA2 | 0.31878865 |
| 115 | TSSK6 | 0.31576889 |
| 116 | TTN | 0.31173389 |
| 117 | MAP3K1 | 0.30568312 |
| 118 | MELK | 0.30048957 |
| 119 | ACVR1B | 0.28425034 |
| 120 | TAOK1 | 0.27161458 |
| 121 | RPS6KC1 | 0.26726527 |
| 122 | RPS6KL1 | 0.26726527 |
| 123 | INSR | 0.26252284 |
| 124 | PDGFRB | 0.25733302 |
| 125 | HIPK2 | 0.25291240 |
| 126 | MAPK4 | 0.24959286 |
| 127 | MAP3K8 | 0.23913233 |
| 128 | CDK9 | 0.23183224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.21830151 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.16577419 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.77795377 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.77002828 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63890871 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.53050259 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.41982549 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29705834 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.27327787 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.25994911 |
| 11 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.18923206 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17253913 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.17102042 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10586672 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07612467 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.04945954 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00127109 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.97115477 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94768582 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.90393671 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.87802109 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.79269502 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.78074401 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.76774369 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70599399 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.66776255 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66558962 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61237607 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56924626 |
| 30 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49893244 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49395188 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.47034092 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44870901 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44528279 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40393760 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.39750233 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.32479925 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.26766085 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25880125 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22004913 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19522930 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18027985 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15889487 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.14042144 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.13146786 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07370217 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05696502 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03676758 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96672000 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94078832 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92809855 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88233501 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.85654909 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.84680332 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83303492 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.81460466 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.80691473 |
| 58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74105098 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73128156 |
| 60 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72315706 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70517228 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69085962 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67572209 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65697682 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64590847 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62480598 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.61944509 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.56917606 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.56889951 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56575269 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55589438 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54596781 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52919747 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50230112 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49784053 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48053014 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45102184 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42931002 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39015577 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37181207 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34559855 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.34520710 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34251685 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34093493 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32913581 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.31977640 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31492364 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31489337 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31234529 |
| 90 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30116924 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.29074377 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28641544 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.28264444 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27873100 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.27009620 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25918021 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25810063 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25746763 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.24743079 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.24391082 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.24152521 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.23368227 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23261098 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22001536 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21384466 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20128669 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.17954060 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.17784121 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17225763 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14182078 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13849154 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.13767246 |

